Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
PUT
Crown Castle
CCI
$32.4B
| $1.21M | ﹤0.01% |
10,600
-500
| -5% | -$59.5K |
|
3827
Telkom Indonesia
TLK
$14.4B
| $1.21M | ﹤0.01% |
45,273
+36,452
| +413% | +$1.01M |
|
|
TEF
3828
DELISTED
Telefonica
TEF
| $1.21M | ﹤0.01% |
299,484
+148,705
| +99% | +$630K |
|
3829
CALL
Keysight
KEYS
$54.5B
| $1.21M | ﹤0.01% |
7,200
+5,800
| +414% | +$900K |
|
3830
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29B
| $1.2M | ﹤0.01% |
34,121
+10,824
| +46% | +$380K |
|
|
THRX
3831
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.2M | ﹤0.01% |
128,995
+48,960
| +61% | +$482K |
|
|
CNR
3832
Core Natural Resources Inc
CNR
$5.01B
| $1.2M | ﹤0.01% |
17,746
-252,349
| -93% | -$15.4M |
|
3833
Rigetti Computing
RGTI
$5.2B
| $1.2M | ﹤0.01% |
+1,021,903
| New | +$766K |
|
3834
PVH
PVH
$3.49B
| $1.2M | ﹤0.01% |
14,121
-144,212
| -91% | -$12.2M |
|
3835
nLIGHT
LASR
$2.48B
| $1.2M | ﹤0.01% |
77,664
-14,377
| -16% | -$176K |
|
3836
Trip.com Group
TCOM
$28.6B
| $1.2M | ﹤0.01% |
34,199
-306,847
| -90% | -$10.7M |
|
3837
Willis Lease Finance
WLFC
$1.13B
| $1.2M | ﹤0.01% |
91,755
-885
| -1% | -$13.7K |
|
|
CONN
3838
DELISTED
Conn's Inc.
CONN
| $1.2M | ﹤0.01% |
323,357
+83,982
| +35% | +$380K |
|
|
FRG
3839
DELISTED
Franchise Group, Inc.
FRG
| $1.2M | ﹤0.01% |
41,761
-14,818
| -26% | -$425K |
|
3840
EverCommerce
EVCM
$1.63B
| $1.19M | ﹤0.01% |
+100,923
| New | +$1.18M |
|
|
ALPN
3841
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.19M | ﹤0.01% |
+116,175
| New | +$1.05M |
|
3842
CALL
ARK Genomic Revolution ETF
ARKG
$1.88B
| $1.19M | ﹤0.01% |
35,000
-5,000
| -13% | -$157K |
|
|
SGMO
3843
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.19M | ﹤0.01% |
917,454
+609,121
| +198% | +$832K |
|
3844
CALL
Steris
STE
$22.8B
| $1.19M | ﹤0.01% |
5,300
-22,900
| -81% | -$4.58M |
|
3845
Modine Manufacturing
MOD
$9.43B
| $1.19M | ﹤0.01% |
36,092
-9,125
| -20% | -$228K |
|
3846
Playboy Inc
PLBY
$144M
| $1.19M | ﹤0.01% |
708,876
+661,002
| +1,381% | +$1.12M |
|
3847
GEN Restaurant Group
GENK
$10.2M
| $1.19M | ﹤0.01% |
+70,046
| New | +$1.1M |
|
3848
Intercorp Financial Services
IFS
$6.03B
| $1.19M | ﹤0.01% |
47,878
-99,015
| -67% | -$2.28M |
|
3849
PUT
Revvity
RVTY
$14.4B
| $1.19M | ﹤0.01% |
10,000
-5,000
| -33% | -$615K |
|
3850
National Presto Industries
NPK
$1.09B
| $1.18M | ﹤0.01% |
+16,184
| New | +$1.19M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.